HERCULES, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the release of beta version of USP Spectral Library™ powered by Bio Rad’s KnowItAll® software technology platform for spectral analysis, identification, search, data management, and reporting.

The USP Spectral Library Project is a new interactive, authoritative, and comprehensive collection of spectral information on food and drug quality. Manufacturers can use the USP Spectral Library on the KnowItAll platform for raw material identification during routine quality control measures to confirm the identity of active pharmaceutical ingredients (APIs) and excipients used in their products.

With applications in quality standards development, rapid screening in the field for counterfeit and substandard foods and medicines based on portable analytical technology, and the identification of raw materials as well as finished products, the USP Spectral Library can be a useful tool for regulatory authorities, law enforcement agencies, hospitals, pharmacies, manufacturers, and distributors around the world.

To ensure the highest quality, USP generates spectra for the USP Spectral Library using the collaborative testing model for which USP is renowned. The resulting spectral databases are made available in the KnowItAll platform in a new, Bio-Rad self-validating 21 CFR Part 11-compliant quality control application called QC Expert™.

“The USP Spectral Library has the potential to help ensure the quality of medicines and foods throughout the world,” said Ed Zhao, USP’s Vice President of Business Development and Allied Compendial Programs.

“Bio-Rad is honored to partner with USP on such an important project for quality control within the pharmaceutical and food industries,” said Gregory M. Banik, Ph.D., General Manager, Bio-Rad Informatics. “We are delighted that Bio-Rad’s KnowItAll technology platform was such a perfect fit to bring USP’s innovative vision for the USP Spectral Library to commercial reality.”

Learn more at https://www.knowitall.com/usp

About The U.S. Pharmacopeial Convention

The U.S. Pharmacopeial Convention (USP) is a global health organization that improves lives through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP’s standards are used worldwide. For more information about USP visit https://www.usp.org.

About Bio-Rad’s KnowItAll Software

Bio-Rad’s award-winning KnowItAll software offers comprehensive solutions for spectral analysis, identification, search, data management, and reporting. It supports multiple instrument vendor file formats and techniques (IR, Raman, NIR, NMR, MS, UV-Vis). The software, combined with one of the world’s largest spectral reference collections (over 1.4 million spectra), helps chemists extract even greater knowledge from their spectral data.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and industry customers through its global network of operations. The company employs approximately 7,750 people worldwide and had revenues exceeding $2 billion in 2013. https://www.bio-rad.com

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.